1
|
Zhang R, Wang X, Xie Z, Cao T, Jiang S, Huang L. Lipoxin A4 methyl ester attenuated ketamine-induced neurotoxicity in SH-SY5Y cells via regulating leptin pathway. Toxicol In Vitro 2023; 89:105581. [PMID: 36907275 DOI: 10.1016/j.tiv.2023.105581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 02/18/2023] [Accepted: 03/08/2023] [Indexed: 03/13/2023]
Abstract
Ketamine, the widely used intravenous anesthetic, has been reported to cause neurotoxicity and disturbs normal neurogenesis. However, the efficacy of current treatment strategies targeting ketamine's neurotoxicity remains limited. Lipoxin A4 methyl ester (LXA4 ME) is relatively stable lipoxin analog, which serves an important role in protecting against early brain injury. The purpose of this study was to investigate the protective effect of LXA4 ME on ketamine-caused cytotoxicity in SH-SY5Y cells, as well as the underlying mechanisms. Cell viability, apoptosis and endoplasmic reticulum stress (ER stress) were detected by adopting experimental techniques including CCK-8 assay, flow cytometry, western blotting and transmission electron microscope. Furthermore, examining the expression of leptin and its receptor (LepRb), we also measured the levels of activation of the leptin signaling pathway. Our results showed that LXA4 ME intervention promoted the cell viability, inhibited cell apoptosis, and reduced the expression of ER stress related protein and morphological changes induced by ketamine. In addition, inhibition of leptin signaling pathway caused by ketamine could be reversed by LXA4 ME. However, as the specific inhibitor of leptin pathway, leptin antagonist triple mutant human recombinant (leptin tA) attenuated the cytoprotective effect of LXA4 ME against ketamine-induced neurotoxicity. In conclusion, our findings demonstrated LXA4 ME could exert a neuroprotective effect on ketamine-induced neuronal injury via activation of the leptin signaling pathway.
Collapse
Affiliation(s)
- Rui Zhang
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, No 215 Heping west road, Shijiazhuang, Hebei, China; Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People's Hospital), No. 1166, Dongfanghong West Road, Decheng District, Dezhou City, Shandong Province, China
| | - Xueji Wang
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, No 215 Heping west road, Shijiazhuang, Hebei, China; Hebei Medical University, No.48, Donggang Road, Shijiazhuang, Hebei, China
| | - Ziyu Xie
- Hebei Medical University, No.48, Donggang Road, Shijiazhuang, Hebei, China
| | - Tianyu Cao
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, No 215 Heping west road, Shijiazhuang, Hebei, China
| | - Sufang Jiang
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, No 215 Heping west road, Shijiazhuang, Hebei, China
| | - Lining Huang
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, No 215 Heping west road, Shijiazhuang, Hebei, China.
| |
Collapse
|
2
|
Lužná V, Liška K, Sládek M, Sumová A. Hormonal fine-tuning of clock in decidual region of mouse placenta by dopamine, melatonin, insulin, leptin and ghrelin. Placenta 2021; 108:55-63. [PMID: 33819862 DOI: 10.1016/j.placenta.2021.03.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Revised: 03/19/2021] [Accepted: 03/23/2021] [Indexed: 10/21/2022]
Abstract
INTRODUCTION The maternal part of the rodent placenta harbors a circadian clock which robustly responds to glucocorticoids, however, its sensitivity to other hormones has not been elucidated. In this study, we tested five selected hormones (dopamine, melatonin, insulin, leptin and ghrelin) for their effectiveness to affect the clock in decidual region of mouse placenta in vitro. METHODS We administered the hormones or corresponding vehicles at various time points over 24 h to organotypic placental explants of mPer2Luc mice containing the decidua basalis (DB) region and monitored their effects on amplitude, period, median expression level (mesor) and phase of PER2-driven bioluminescence rhythms. RESULTS Dopamine significantly increased the amplitude, robustly dampened the mesor, and during a narrow time interval (corresponding to daytime) induced phase delays of the rhythms. In contrast, melatonin had no effect on amplitude, but induced phase advances of the rhythms at the opposite time window than dopamine (corresponding to nighttime). Leptin and ghrelin, but not insulin, slightly increased amplitudes and moderately modulated phase delays of the clock, suggesting that the DB clock, in contrast to other peripheral clocks, is rather resilient to abrupt changes in levels of feeding- and metabolism-related hormones. DISCUSSION The results demonstrate for the first time that dopamine and melatonin exhibit delicate yet specific effects on parameters of the DB clock and may thus potentially contribute to fine-tuning of its phase under in vivo conditions. It also implies that dysregulation of their levels, which accompany various pathologies, may account for malfunction of the clock in DB.
Collapse
Affiliation(s)
- Vendula Lužná
- Laboratory of Biological Rhythms, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic
| | - Karolína Liška
- Laboratory of Biological Rhythms, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
| | - Martin Sládek
- Laboratory of Biological Rhythms, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
| | - Alena Sumová
- Laboratory of Biological Rhythms, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
| |
Collapse
|
3
|
Chakraborty D, Benham V, Bernard JJ. Elucidating the role of adipose tissue secreted factors in malignant transformation. Adipocyte 2018; 7:45-48. [PMID: 29095087 DOI: 10.1080/21623945.2017.1388971] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Although there is a growing number of incidences of obesity and obesity-linked cancers, how excess adiposity actually causes cancer has not been fully explained. Our previous study showed that removal of visceral adipose tissue significantly reduced the number of ultraviolet radiation (UVR)-initiated, high-fat diet-promoted skin cancers. This commentary focuses on our recently published study (Chakraborty, et al., 2017) which demonstrated that fibroblast growth factor-2 (FGF2) released from visceral adipose tissue is a key factor in the malignant transformation of epithelial cells. Within this commentary we have provided additional interpretations and new data in support of the role of FGF2 in adiposity-associated tumorigenesis.
Collapse
Affiliation(s)
- Debrup Chakraborty
- Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA
| | - Vanessa Benham
- Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA
| | - Jamie J. Bernard
- Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA
| |
Collapse
|
4
|
Pennington KA, Ramirez-Perez FI, Pollock KE, Talton OO, Foote CA, Reyes-Aldasoro CC, Wu HH, Ji T, Martinez-Lemus LA, Schulz LC. Maternal Hyperleptinemia Is Associated with Male Offspring's Altered Vascular Function and Structure in Mice. PLoS One 2016; 11:e0155377. [PMID: 27187080 PMCID: PMC4871503 DOI: 10.1371/journal.pone.0155377] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2016] [Accepted: 04/27/2016] [Indexed: 12/27/2022] Open
Abstract
Children of mothers with gestational diabetes have greater risk of developing hypertension but little is known about the mechanisms by which this occurs. The objective of this study was to test the hypothesis that high maternal concentrations of leptin during pregnancy, which are present in mothers with gestational diabetes and/or obesity, alter blood pressure, vascular structure and vascular function in offspring. Wildtype (WT) offspring of hyperleptinemic, normoglycemic, Leprdb/+ dams were compared to genotype matched offspring of WT-control dams. Vascular function was assessed in male offspring at 6, and at 31 weeks of age after half the offspring had been fed a high fat, high sucrose diet (HFD) for 6 weeks. Blood pressure was increased by HFD but not affected by maternal hyperleptinemia. On a standard diet, offspring of hyperleptinemic dams had outwardly remodeled mesenteric arteries and an enhanced vasodilatory response to insulin. In offspring of WT but not Leprdb/+ dams, HFD induced vessel hypertrophy and enhanced vasodilatory responses to acetylcholine, while HFD reduced insulin responsiveness in offspring of hyperleptinemic dams. Offspring of hyperleptinemic dams had stiffer arteries regardless of diet. Therefore, while maternal hyperleptinemia was largely beneficial to offspring vascular health under a standard diet, it had detrimental effects in offspring fed HFD. These results suggest that circulating maternal leptin concentrations may interact with other factors in the pre- and post -natal environments to contribute to altered vascular function in offspring of diabetic pregnancies.
Collapse
Affiliation(s)
- Kathleen A. Pennington
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
| | - Francisco I. Ramirez-Perez
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
- Department of Biological Engineering, University of Missouri, Columbia, Missouri, United States of America
| | - Kelly E. Pollock
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
| | - Omonseigho O. Talton
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
- Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
| | - Christopher A. Foote
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
| | | | - Ho-Hsiang Wu
- Department of Statistics, University of Missouri, Columbia, Missouri, United States of America
| | - Tieming Ji
- Department of Statistics, University of Missouri, Columbia, Missouri, United States of America
| | - Luis A. Martinez-Lemus
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
- Department of Biological Engineering, University of Missouri, Columbia, Missouri, United States of America
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri, United States of America
- * E-mail: (LAM); (LCS)
| | - Laura C. Schulz
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
- Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
- * E-mail: (LAM); (LCS)
| |
Collapse
|
5
|
Martino J, Sebert S, Segura MT, García-Valdés L, Florido J, Padilla MC, Marcos A, Rueda R, McArdle HJ, Budge H, Symonds ME, Campoy C. Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes. J Clin Endocrinol Metab 2016; 101:59-68. [PMID: 26513002 PMCID: PMC4701853 DOI: 10.1210/jc.2015-2590] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
CONTEXT Maternal obesity and gestational diabetes mellitus (GDM) can both contribute to adverse neonatal outcomes. The extent to which this may be mediated by differences in placental metabolism and nutrient transport remains to be determined. OBJECTIVE Our objective was to examine whether raised maternal body mass index (BMI) and/or GDM contributed to a resetting of the expression of genes within the placenta that are involved in energy sensing, oxidative stress, inflammation, and metabolic pathways. METHODS Pregnant women from Spain were recruited as part of the "Study of Maternal Nutrition and Genetics on the Foetal Adiposity Programming" survey at the first antenatal visit (12-20 weeks of gestation) and stratified according to prepregnancy BMI and the incidence of GDM. At delivery, placenta and cord blood were sampled and newborn anthropometry measured. RESULTS Obese women with GDM had higher estimated fetal weight at 34 gestational weeks and a greater risk of preterm deliveries and cesarean section. Birth weight was unaffected by BMI or GDM; however, women who were obese with normal glucose tolerance had increased placental weight and higher plasma glucose and leptin at term. Gene expression for markers of placental energy sensing and oxidative stress, were primarily affected by maternal obesity as mTOR was reduced, whereas SIRT-1 and UCP2 were both upregulated. In placenta from obese women with GDM, gene expression for AMPK was also reduced, whereas the downstream regulator of mTOR, p70S6KB1 was raised. CONCLUSIONS Placental gene expression is sensitive to both maternal obesity and GDM which both impact on energy sensing and could modulate the effect of either raised maternal BMI or GDM on birth weight.
Collapse
Affiliation(s)
- J Martino
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - S Sebert
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M T Segura
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - L García-Valdés
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - J Florido
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M C Padilla
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - A Marcos
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - R Rueda
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - H J McArdle
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - H Budge
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - M E Symonds
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| | - C Campoy
- Early Life Research Unit (J.M., S.S., H.B., M.E.S.), Division of Child Health and Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom; EURISTIKOS Excellence Centre for Paediatric Research (J.M., M.T.S., L.G.-V., C.C.), University of Granada, 18016 Granada, Spain; Department of Obstetrics and Gynaecology (J.F., M.C.P.), University of Granada, Granada, Spain; Immunonutrition Research Group (A.M.), Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition, Spanish National Research Council, E-28040 Madrid, Spain; Abbott Nutrition (R.R.), 18004 Granada, Spain; The Rowett Institute of Nutrition and Health (H.J.M.), University of Bucksburn, Aberdeen, AB21 9SB,United Kingdom; Institute of Health Sciences and Biocenter Oulu (S.S.), University of Oulu, 90014 Oulu, Finland
| |
Collapse
|
6
|
Pérez-Pérez A, Sánchez-Jiménez F, Maymó J, Dueñas JL, Varone C, Sánchez-Margalet V. Role of leptin in female reproduction. Clin Chem Lab Med 2015; 53:15-28. [PMID: 25014521 DOI: 10.1515/cclm-2014-0387] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2014] [Accepted: 06/16/2014] [Indexed: 12/26/2022]
Abstract
Reproductive function is dependent on energy resources. The role of weight, body composition, fat distribution and the effect of diet have been largely investigated in experimental female animals as well as in women. Any alteration in diet and/or weight may induce abnormalities in timing of sexual maturation and fertility. However, the cellular mechanisms involved in the fine coordination of energy balance and reproduction are largely unknown. The brain and hypothalamic structures receive endocrine and/or metabolic signals providing information on the nutritional status and the degree of fat stores. Adipose tissue acts both as a store of energy and as an active endocrine organ, secreting a large number of biologically important molecules termed adipokines. Adipokines have been shown to be involved in regulation of the reproductive functions. The first adipokine described was leptin. Extensive research over the last 10 years has shown that leptin is not only an adipose tissue-derived messenger of the amount of energy stores to the brain, but also a crucial hormone/cytokine for a number of diverse physiological processes, such as inflammation, angiogenesis, hematopoiesis, immune function, and most importantly, reproduction. Leptin plays an integral role in the normal physiology of the reproductive system with complex interactions at all levels of the hypothalamic-pituitary gonadal (HPG) axis. In addition, leptin is also produced by placenta, where it plays an important autocrine function. Observational studies have demonstrated that states of leptin excess, deficiency, or resistance can be associated with abnormal reproductive function. This review focuses on the leptin action in female reproduction.
Collapse
|
7
|
Tsai PJS, Davis J, Bryant-Greenwood G. Systemic and placental leptin and its receptors in pregnancies associated with obesity. Reprod Sci 2014; 22:189-97. [PMID: 24899470 DOI: 10.1177/1933719114537718] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
This study aimed to gain new insights into both systemic and placental leptin and its receptors, with reference to the maternal prepregnancy body mass index (BMI). Thus, 84 women (29 lean, 24 overweight, and 31 obese) were recruited and maternal, cord blood, and placental tissues collected prior to term labor. Plasma levels were measured by enzyme-linked immunosorbent assay and for placenta, immunohistochemistry and messenger RNAs (mRNAs) were quantitated. We confirmed that maternal leptin increased linearly as the soluble receptor decreased with BMI (P = .001). Fetal leptin increased with maternal BMI (P = .02) and birth weight (P = .006) and was higher in female infants (P < .001). Placental mRNA levels of leptin and its receptors showed no change in BMI. However, we show a significant (P = .043) linear increase in leptin in the placental vascular endothelial cells with maternal obesity, while leptin in syncytiotrophoblast showed no statistical change. Leptin receptors localized to syncytiotrophoblast and intravillous macrophages and were unchanged with BMI.
Collapse
Affiliation(s)
- Pai-Jong Stacy Tsai
- Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA
| | - James Davis
- John A. Burns School of Medicine, University of Hawaii, Biostatistic Core, Honolulu, HI, USA
| | - Gillian Bryant-Greenwood
- Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA
| |
Collapse
|
8
|
Tessier D, Ferraro Z, Gruslin A. Role of leptin in pregnancy: Consequences of maternal obesity. Placenta 2013; 34:205-11. [DOI: 10.1016/j.placenta.2012.11.035] [Citation(s) in RCA: 100] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2012] [Revised: 11/23/2012] [Accepted: 11/29/2012] [Indexed: 10/27/2022]
|
9
|
Liu ZK, Liu HY, Fang WN, Yang Y, Wang HM, Peng JP. Insulin-like growth factor binding protein 7 modulates estrogen-induced trophoblast proliferation and invasion in HTR-8 and JEG-3 cells. Cell Biochem Biophys 2012; 63:73-84. [PMID: 22383111 DOI: 10.1007/s12013-012-9342-5] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Previous research has reported that IGFBP7 functions as a tumor suppressor gene in different tumors, but its role in the trophoblast has not been elucidated. In this research, we studied the regulation mechanism of IGFBP7 in trophoblast proliferation and invasion in HTR-8 and JEG-3 cell lines. We found that IGFBP7 was abundantly expressed in normal human syncytiotrophoblast tissue samples but that this was lacking in hydatidiform moles. The proliferation and invasion capacities of HTR-8 and JEG-3 cells were significantly inhibited by recombinant IGFBP7. Estrogen (E2) stimulated the expression of IGFBP7 at a concentration of 5-10 ng/mL. This stimulation was inhibited by the estrogen receptor antagonist Fulvestrant (ICI182.780) and a TGFβ-neutralizing antibody. In conclusion, our data reveals that estrogen stimulates the expression of IGFBP7 through estrogen receptors and TGFβ. The expression of IGFBP7 could be stimulated by TGFβ in a dose-dependent manner and inhibited by IFNγ in HTR-8 and JEG-3 cells. IGFBP7 could also inhibit the phosphorylation of ERK and the expression of PCNA, MMP2 and MMP9 in HTR-8 and JEG-3 cells. These findings suggest that IGFBP7 is a key regulator of E2-induced trophoblast proliferation and invasion.
Collapse
Affiliation(s)
- Zhen-Kun Liu
- State Key Laboratory of Reproductive Biology, Institute of Zoology of Chinese Academy of Sciences, Chaoyang District, Beijing, People's Republic of China
| | | | | | | | | | | |
Collapse
|
10
|
D'Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 2012; 38:14-23. [PMID: 22287297 DOI: 10.1002/biof.201] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2011] [Accepted: 12/28/2011] [Indexed: 01/03/2023]
Abstract
Latter half of pregnancy is characterized by a "physiological diabetogenic state" since changes in insulin-sensitivity have been well documented. These changes ensure continuous supply of nutrients to the growing fetus. In the last years the role of adipocyte-derived signaling molecules, collectively known as adipokines has been object of different in vitro and in vivo studies. Of interest, adipokines and/or their receptors are expressed in the placental tissue which, therefore, can contribute to development of maternal insulin-resistance and, as a consequence, fetal growth. Leptin, adiponectin, and resistin represent the most well studied adipokines and, with the exception of adiponectin, their serum and placental levels increase as pregnancy progresses. High levels of adipokines have also been detected in umbilical plasma hence suggesting a possible role on fetal development and metabolism; however, it remains still unclear if such adipokines can directly stimulate fetal tissues development acting as growth factors. In addition to their well known metabolic effects, we also reported studies describing the role of adipokines in promoting proliferation and invasiveness of trophoblast cells and affecting local angiogenic processes. These observations strongly suggest that adipokines, by alternatively interfering with placental development, may affect pregnancy outcome and fetal growth. However, further studies are needed to better understand the local regulation of their expression. © 2012 International Union of Biochemistry and Molecular Biology, Inc.
Collapse
Affiliation(s)
- Silvia D'Ippolito
- Department of Obstetrics and Gynecology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
| | | | | | | |
Collapse
|
11
|
Masumoto A, Takamoto N, Masuyama H, Akahori Y, Inoue S, Hiramatsu Y. Effects of intermittent high glucose on BeWo choriocarcinoma cells in culture. J Obstet Gynaecol Res 2011; 37:1365-75. [PMID: 21599799 DOI: 10.1111/j.1447-0756.2011.01539.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
AIM The aim of this study was to investigate the cellular effects of intermittent high glucose on the human BeWo placental choriocarcinoma cell line, used as a model of the effects of glucose fluctuation in diabetic pregnancies. MATERIALS AND METHODS BeWo cells were subjected to three different glucose conditions for 48 h: 7 mmol/L (control), 42 mmol/L (high glucose), or 7 and 42 mmol/L glucose (intermittent, alternated every 6 h). Cell viability was assessed using cell counts, a cell proliferation assay, and a cell viability assay. Apoptosis was also studied using a terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay and by immunocytochemistry of fractin, the N-terminal fragment of actin, which can distinguish apoptotic from necrotic cells. Furthermore, the expression of the well-known survival factors of trophoblast cells, heparin-binding epidermal growth factor-like growth factor and leptin, was evaluated by real-time polymerase chain reaction and Western blot analyses. RESULTS Intermittent high-glucose conditions significantly decreased cell viability and enhanced apoptosis compared with control or continuous high-glucose conditions. Furthermore, the expression of heparin-binding epidermal growth factor-like growth factor, but not that of leptin, was significantly increased under intermittent high-glucose conditions compared to its expression under either control or continuous high-glucose conditions. CONCLUSIONS These data indicate that intermittent high glucose is more deleterious to BeWo cells than continuous high-glucose conditions. Although further in vitro and in vivo study is necessary, excess fluctuation of glucose levels in the placental circulation might be involved in the impairment of placental development leading to the placental dysfunction.
Collapse
Affiliation(s)
- Akio Masumoto
- Department of Obstetrics and Gynecology, Hiroshima City Hospital, Hiroshima, Japan.
| | | | | | | | | | | |
Collapse
|
12
|
Schulz LC, Widmaier EP, Qiu J, Roberts RM. Effect of leptin on mouse trophoblast giant cells. Biol Reprod 2009; 80:415-24. [PMID: 19038858 PMCID: PMC2805391 DOI: 10.1095/biolreprod.108.073130] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2008] [Revised: 09/08/2008] [Accepted: 10/20/2008] [Indexed: 01/29/2023] Open
Abstract
Leptin plays a role in both energy homeostasis and reproduction, and it is required in early pregnancy. It stimulates metalloproteinase activity in cultured human trophoblasts and invasiveness of cultured mouse trophoblasts. Our goal has been to examine mechanisms that underpin the ability of leptin to promote trophoblast invasiveness in primary cultures of mouse trophoblasts. Leptin stimulated the phosphorylation of MEK (MAP2K1) but not signal transducer and activator of transcription 3 (STAT3) in the cultures, increased the concentration of the suppressor of cytokine signaling 3 (SOCS3) protein, and upregulated metalloproteinase activity. Microarray analysis revealed that leptin stimulated select genes with roles in cell motility, including Stmn, a gene linked to invasiveness in other cell types. There was also an increase in activity of several genes associated with MAPK and RhoGTPase signaling. In addition, leptin muted expression of genes correlated with terminal differentiation of trophoblast giant cells, including ones associated with the TGFbeta signaling pathway and endoreduplication of DNA, and upregulated selected prolactin-related family members. Feulgen staining of leptin-treated cells revealed a loss of cells with low ploidy. The data suggest that leptin accelerates disappearance of non-giant cells while inhibiting terminal differentiation of committed giant cells, possibly by maintaining cells in an intermediate stage of differentiation.
Collapse
Affiliation(s)
- L C Schulz
- Division of Animal Sciences, University of Missouri, Columbia, Missouri 65211, USA.
| | | | | | | |
Collapse
|
13
|
Lepercq J, Catalano P, Hauguel de Mouzon S. Leptine et grossesse: dogmes, questions et perspectives. ACTA ACUST UNITED AC 2007; 35:89-95. [PMID: 17276124 DOI: 10.1016/j.gyobfe.2006.12.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2006] [Accepted: 12/28/2006] [Indexed: 10/23/2022]
Abstract
Leptin has been primarily considered as a protein secreted by the adipocyte and a regulator of satiety and energy homeostasis. A role for leptin in pregnancy was later suggested as circulating levels of leptin are high in the pregnant woman and leptin is synthetized within the placenta. Placental leptin production is increased in various obstetrical conditions associated with alterations of fetal growth (diabetes, preeclampsia). Furthermore, umbilical leptin can be viewed as a biomarker of fetal adiposity. Our aim is to review the putative roles of leptin in pregnancy.
Collapse
Affiliation(s)
- J Lepercq
- Service de Gynécologie-Obstétrique, Groupe Hospitalier Cochin-Saint-Vincent-de-Paul (APHP), 82, avenue Denfert-Rochereau, 75674 Paris cedex 14, France.
| | | | | |
Collapse
|
14
|
Schulz LC, Townsend K, Kunz TH, Widmaier EP. Inhibition of trophoblast invasiveness in vitro by immunoneutralization of leptin in the bat, Myotis lucifugus (Chiroptera). Gen Comp Endocrinol 2007; 150:59-65. [PMID: 16938297 DOI: 10.1016/j.ygcen.2006.07.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2006] [Revised: 07/06/2006] [Accepted: 07/13/2006] [Indexed: 10/24/2022]
Abstract
In addition to effects on metabolism and appetite, leptin is a reproductive hormone produced and secreted by the placenta of many, but not all mammalian species. In mice, in which the placenta does not secrete leptin, exogenously added leptin stimulates invasiveness of early (but not late)-gestation trophoblast cells. We report a similar phenomenon occurs in Myotis lucifugus (little brown myotis), a species in which the placenta synthesizes and secretes leptin. Immunoneutralization of endogenously secreted leptin from cultured M. lucifugus trophoblast cells inhibited the ability of these cells to invade a matrigel matrix. The effect was not due to an inhibitory effect of the antibody on cell proliferation, nor was it a non-specific effect of antibody administration. Cell invasion was significantly reduced in untreated cells obtained from late-gestation placentas, and the antibody had no effect at that time. This occurred despite continued expression throughout gestation of the long (OBRb) and short (OBRa) isoforms of leptin receptor mRNA. This study suggests that an important function of leptin during pregnancy is an effect on trophoblast cell invasiveness, at a time when the placenta is becoming established. That this occurs in two phylogenetically unrelated and distant species, regardless of whether the placenta is a source of secreted leptin, suggests that this is a highly conserved reproductive action of leptin.
Collapse
Affiliation(s)
- Laura C Schulz
- Department of Biology, Boston University, Boston, MA 02215, USA.
| | | | | | | |
Collapse
|
15
|
Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006; 194:1537-45. [PMID: 16731069 DOI: 10.1016/j.ajog.2005.06.064] [Citation(s) in RCA: 165] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2005] [Revised: 05/16/2005] [Accepted: 06/14/2005] [Indexed: 01/12/2023]
Abstract
Leptin, which was identified originally as an adipocyte-derived protein, was regarded for years as an exclusive regulator of satiety and energy homeostasis. A role for leptin in pregnancy was later suggested by the findings that plasma levels during gestation are greater than in nongravid individuals and that leptin is synthesized within the fetoplacental unit. Observational studies have established that leptin production is dysregulated in several pathologic stages of pregnancy in association with alterations of fetal growth. For example, an overproduction of leptin by the placenta in pregnancy with diabetes mellitus or hypertension is associated with maternal hyperleptinemia. Evidence is also accumulating that umbilical leptin levels can be viewed as a biomarker of fetal adiposity. Ten years after its discovery as a hormone, we review the known and unknowns of leptin in pregnancy with particular emphasis on its functions in health and disease. We aim to demonstrate that studies of leptin in pregnancy largely have contributed to insight into the mechanisms of leptin action, both as a hormone and as a cytokine.
Collapse
|
16
|
James JL, Stone PR, Chamley LW. The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update 2005; 12:137-44. [PMID: 16234296 DOI: 10.1093/humupd/dmi043] [Citation(s) in RCA: 121] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
In the first trimester of human pregnancy villous cytotrophoblasts are able to differentiate to form either the overlying syncytiotrophoblast layer or, in anchoring villi, extravillous trophoblasts which grow out from the villi and invade into the maternal decidua, acting to both physically attach the placenta to the decidua, and modify the maternal spiral arteries to sustain pregnancy. During the first 10-12 weeks of gestation, extravillous trophoblast plugs block the spiral arteries and prevent maternal blood flow entering the intervillous space, thereby creating an environment of physiological hypoxia in which placental and fetal development occur. As extravillous trophoblasts migrate away from the villus they differentiate from a proliferative to an invasive phenotype. The hypoxic environment of the first trimester is believed to play an important role in the regulation of trophoblast differentiation. However, there is currently a large body of conflicting experimental evidence concerning this topic. This review examines the experimental evidence to date on the role of oxygen in trophoblast differentiation.
Collapse
Affiliation(s)
- J L James
- Department of Obstetrics and Gynecology, University of Auckland, Auckland, New Zealand.
| | | | | |
Collapse
|
17
|
Wyrwoll CS, Mark PJ, Waddell BJ. Directional secretion and transport of leptin and expression of leptin receptor isoforms in human placental BeWo cells. Mol Cell Endocrinol 2005; 241:73-9. [PMID: 15955620 DOI: 10.1016/j.mce.2005.05.003] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2004] [Revised: 05/03/2005] [Accepted: 05/06/2005] [Indexed: 11/23/2022]
Abstract
Placental leptin secretion has important implications for maternal adaptation to pregnancy, fetal growth and development, and local autocrine/paracrine actions within trophoblast. In this study we used a cell culture insert model to examine directional secretion of leptin from the basal and apical surfaces of human choriocarcinoma BeWo cells, and to assess the effects of dexamethasone and syncytialization. Additionally, the effects of dexamethasone on transcellular passage of leptin across BeWo monolayers, and on expression of the leptin receptor isoforms Ob-Rs and Ob-RL were examined. Leptin was secreted into both the basal and apical chambers and was stimulated by dexamethasone. Treatment of BeWo cells with forskolin induced syncytialization and loss of monolayer integrity, but resulted in a marked increase in total leptin secretion, an effect further enhanced by co-treatment with dexamethasone. Bidirectional transfer of 125I-leptin between the apical and basal chambers of BeWo cell cultures was low but indicative of specific transcellular passage of leptin; transfer was unaffected by dexamethasone. Treatment of BeWo cells with forskolin increased Ob-Rs mRNA expression, whilst Ob-RL mRNA expression increased in response to forskolin only in the presence of dexamethasone. In conclusion, our data show that leptin is secreted from both the apical and basal surfaces of BeWo placental cells and is increased by both syncytialization and glucocorticoids. Moreover, transport of exogenous leptin occurred in both the apical to basal and reverse directions, suggesting the potential for maternal-fetal exchange of leptin across the human placenta.
Collapse
Affiliation(s)
- Caitlin S Wyrwoll
- School of Anatomy and Human Biology, The University of Western Australia, 35 Stirling Hwy, Crawley, WA 6009, Australia
| | | | | |
Collapse
|
18
|
Meissner U, Spranger R, Lehner M, Allabauer I, Rascher W, Dötsch J. Hypoxia-induced leptin production in human trophoblasts does not protect from apoptosis. Eur J Endocrinol 2005; 153:455-61. [PMID: 16131609 DOI: 10.1530/eje.1.01979] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE The ob-gene product, leptin, is an important regulator of placental and fetal development during pregnancy. Leptin, being induced by hypoxia in the placenta, is a known pro-apoptotic molecule in adipose tissue but is also known to inhibit apoptosis in other tissues like neuroblastoma cells. Based on these findings, we investigated if leptin has a pro- or anti-apoptotic effect on a trophoblastic cell line (JAr cells) in the presence or absence of oxygen. METHODS AND RESULTS Measurement of leptin in the supernatant by using ELISA showed hypoxia-induced leptin production in JAr cells in vitro. This could be confirmed by a leptin-specific RT-PCR. By analyzing leptin and/or hypoxia exposed cells with FACS cytometry we found that JAr cells can cope with hypoxia down to oxygen tensions of 1%. At this level, only a small number of cells underwent apoptosis. Interestingly, leptin added to the culture medium in high concentrations was not able to interfere with the rate of proliferation or apoptosis in these cells independent of the oxygen tension. Finally, an anti-caspase-3 and anti-caspase-9 Western blot was performed. Again, no difference in the expression of caspase-3 and -9 under the conditions tested was seen. CONCLUSIONS These results show that leptin, produced by placental cells after hypoxia in vitro, has no influence on the rate of proliferation of these cells. Furthermore, it does not influence apoptotic pathways in the trophoblastic cell line tested under hypoxic and non-hypoxic conditions.
Collapse
Affiliation(s)
- Udo Meissner
- Department of Pediatrics, University of Erlangen-Nürnberg, Loschgestrasse 15, Erlangen 91054, Germany.
| | | | | | | | | | | |
Collapse
|
19
|
Pollheimer J, Knöfler M. Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta 2005; 26 Suppl A:S21-30. [PMID: 15837062 DOI: 10.1016/j.placenta.2004.11.013] [Citation(s) in RCA: 132] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/23/2004] [Indexed: 01/22/2023]
Abstract
The invasive differentiation pathway of trophoblasts is an indispensable physiological process of early human placental development. Formation of anchoring villi, proliferation of cell columns and invasion of extravillous cytotrophoblasts into maternal decidual stroma and vessels induce vascular changes ensuring an adequate blood supply to the growing fetus. Extravillous trophoblast differentiation is regulated by numerous growth factors as well as by extracellular matrix proteins and adhesion molecules expressed at the fetal-maternal interface. These regulatory molecules control cell invasion by modulating activities of matrix-degrading protease systems and ECM adhesion. The differentiation process involves numerous signalling cascades/proteins such as the GTPases RhoA, the protein kinases ROCK, ERK1, ERK2, FAK, PI3K, Akt/protein kinase B and mTOR as well as TGF-beta-dependent SMAD factors. While an increasing number of signalling pathways regulating trophoblast differentiation are being unravelled, downstream effectors such as executing transcription factors remain largely elusive. Here, we summarise our current knowledge on signal transduction cascades regulating invasive trophoblast differentiation. We will focus on cell model systems which are used to study the particular differentiation process and discuss signalling pathways which regulate trophoblast proliferation and motility.
Collapse
Affiliation(s)
- J Pollheimer
- Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
| | | |
Collapse
|
20
|
Tommaselli GA, Pighetti M, Nasti A, D'Elia A, Guida M, Di Carlo C, Bifulco G, Nappi C. Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks' gestation as markers for the development of pre-eclampsia. Gynecol Endocrinol 2004; 19:160-5. [PMID: 15697078 DOI: 10.1080/09513590400007267] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Abstract
Altered Doppler flow velocimetry of the uterine arteries during the second trimester is correlated with the risk of developing pre-eclampsia. Serum levels of leptin, a protein regulating body weight and secreted by the placenta, are higher in women with severe pre-eclampsia. We investigated whether alterations of uterine arteries' Doppler flow velocimetry during the early second-trimester scan were accompanied by changes in leptin levels, and whether these changes might be an early risk factor for pre-eclampsia. We retrospectively selected 50 women with altered uterine artery velocimetry at the second-trimester scan who subsequently developed pre-eclampsia (group A) and 100 women who did not develop pre-eclampsia, divided into two groups: 50 women with normal velocimetry at the second-trimester scan (group B) and 50 women with altered velocimetry at the second-trimester scan (group C). Serum leptin levels during the second and third trimesters and bilateral uterine artery resistance index during the second trimester were evaluated. No differences were observed in serum leptin levels in the second trimester among the three groups. During the third trimester, women in group A showed significantly higher serum leptin levels in comparison with women in groups B and C (p < 0.01). Serum leptin levels do not seem to be a useful early marker for the development of pre-eclampsia in the presence of altered uterine blood flow, and may be a late compensatory mechanism or reflect a generalized response of the trophoblast to hypoxic stimuli.
Collapse
Affiliation(s)
- G A Tommaselli
- Department of Obstetrics and Gynecology, University of Naples 'Federico II', Naples, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Russo VC, Metaxas S, Kobayashi K, Harris M, Werther GA. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004; 145:4103-12. [PMID: 15166121 DOI: 10.1210/en.2003-1767] [Citation(s) in RCA: 108] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Many factors regulate nervous system development, including complex cross-talk between local neuroendocrine systems. The adipocyte-secreted hormone leptin, mainly known for its key roles in nutrition and reproductive balance, may also be involved in neuroanatomical organization, myelination processes, and neuronal/glia maturation. SK-N-SH-SY5Y neuroblastoma cells were employed as an in vitro model of human neuronal cells to determine whether leptin exerts neuroprotective activities. We show that SH-SY5Y cells express leptin, the long and short isoforms of the leptin receptor (ObRl, ObRs). In SH-SY5Y cells, leptin induced signal transducer and activator of transcription (STAT)-3 phosphorylation and suppressor of cytokine signaling-3 mRNA expression. Leptin dose-dependently increased cell number (up to 200% at 1 microm by 48 h, P < 0.01), and at 24-48 h, leptin at 100 nm increased SH-SY5Y cell number by 30-50%, respectively. SH-SY5Y cell viability was reduced in serum-free conditions at 24 h, and addition of leptin at 100 nm significantly reduced apoptosis by approximately 20% (P < 0.001). Leptin's antiapoptotic activity required Janus kinase/STAT, MAPK, and phosphatidylinositol-3-kinase activation because the antiapoptotic effects of leptin were abolished, and caspase-3 immunoreactivity increased in the presence of the specific blockers AG490, U0126, or LY294002. Gene array demonstrated that leptin inhibits apoptosis via potent down-regulation of caspase-10 and TNF-related apoptosis-inducing ligand. Our data thus demonstrate, for the first time, that leptin stimulates, in a time- and dose-dependent manner, neuroblastoma cell proliferation and that the underlying mechanisms involve suppression of apoptosis via the Janus kinase-STAT, phosphatidylinositol-3 kinase, and MAPK pathways that culminate altogether in the down-regulation of the apoptotic factors caspase-10 and TNF-related apoptosis-inducing ligand.
Collapse
Affiliation(s)
- V C Russo
- Centre for Hormone Research, Murdoch Childrens Research Institute, Parkville 3052, Victoria, Australia.
| | | | | | | | | |
Collapse
|
22
|
Zhao J, Townsend KL, Schulz LC, Kunz TH, Li C, Widmaier EP. Leptin receptor expression increases in placenta, but not hypothalamus, during gestation in Mus musculus and Myotis lucifugus. Placenta 2004; 25:712-22. [PMID: 15450389 DOI: 10.1016/j.placenta.2004.01.017] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/15/2004] [Indexed: 12/01/2022]
Abstract
In addition to effects on appetite and metabolism, the hormone leptin is required for reproduction in mammals. Maternal plasma leptin is increased above non-pregnant levels in all mammals thus far examined, including humans. The increase in plasma leptin appears to result in part from upregulation of adipose leptin secretion (e.g., in mice), or from production and secretion of leptin from the placenta (e.g., in humans and some bats). The placenta may also modulate maternal leptin levels via production of a plasma leptin-binding protein (mice, humans). Thus, the placenta plays a coordinating role in regulation of maternal leptin during pregnancy. In this study, the hypothesis that the placenta is also a target organ for leptin in diverse taxa was tested by examining the expression of leptin receptors (Ob-R) in placentae from species of distantly related mammalian taxa, Mus musculus (the laboratory mouse) and Myotis lucifugus (the little brown myotis, also called the little brown bat). A partial sequence of M. lucifugus Ob-R cDNA was first obtained and found to share approximately 78-88% homology at the nucleotide level with known mammalian Ob-R cDNAs. Using probes and primers designed from this sequence, receptor expression was detected in numerous tissues of M. lucifugus, including placenta, which expressed two major receptor isoforms as judged by molecular size. In both species, Ob-R mRNA expression in placenta significantly increased from early to late gestation. Expression of Ob-R mRNA was not affected by cAMP treatment in vitro. The increase in Ob-R mRNA expression in placenta was specific, since Ob-R mRNA expression did not change during gestation in either species in hypothalamus, the major site of the central actions of leptin. Thus, Ob-R is expressed in placenta throughout gestation in mice and bats, and its expression increases over the course of gestation, which raises the possibility that leptin may exert temporally distinct effects on placental growth or function throughout gestation. Because similar placenta-specific changes in leptin receptor expression occurred in species from distantly related mammalian taxa which collectively comprise approximately 70% of all known mammalian species, it is possible that placental actions of leptin are conserved across mammals, even in those species (such as the Swiss-Webster strain of mouse) in which the placenta does not itself produce leptin.
Collapse
Affiliation(s)
- J Zhao
- Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215, USA
| | | | | | | | | | | |
Collapse
|
23
|
Abstract
The hormone leptin is produced by adipose tissue and can function as a signal of nutritional status to the reproductive system. The expression of leptin receptor and, in some species, leptin, in the placenta suggests a role for leptin in placental development, but this role has not been elucidated. Leptin is required at the time of embryo implantation in the leptin-deficient ob/ ob mouse and has been shown to upregulate expression of matrix metalloproteinases (MMPs), enzymes involved in trophoblast invasion, in cultured human trophoblast cells. This led us to the hypothesis that leptin promotes the invasiveness of trophoblast cells crucial to placental development. We found that leptin stimulated mouse trophoblast cell invasion through a matrigel-coated insert on Day 10, but not Day 18 of pregnancy. Optimal stimulation occurred at a concentration of 50 ng/ml leptin, similar to the peak plasma leptin concentration during pregnancy in the mouse. Leptin treatment did not stimulate proliferation of mouse trophoblast cells in primary culture. Leptin stimulation of invasion was prevented by 25 muM GM6001, an inhibitor of MMP activity. Our results suggest that leptin may play a role in the establishment of the placenta during early pregnancy and that this function is dependent on MMP activity. This effect of leptin may represent one mechanism by which body condition affects placental development.
Collapse
Affiliation(s)
- Laura C Schulz
- Department of Biology, Boston University, Boston, Massachusetts 02215, USA.
| | | |
Collapse
|